Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 11 March 2025
Accepted: 24 March 2025
First Online: 5 May 2025
Disclosure
: Lei Zheng receives grant support from Bristol-Myers Squibb, Merck, Abbvie, and Astrazeneca; is a paid consultant/advisory board member at Biosion, Pfizer, Amberstone, Fortress, and Tallac; and holds shares at Amberstone, Alphamab, Cellaration, and Mingruizhiyao. The remaining authors have no conflicts of interest.
